U.S. federal trademark · Serial No. 88787860
Pharmaceutical peptide preparations for use in treating cancer, infectious diseases, and central nervous system disorders, consisting of peptide-based PD1 blockade inhibitors linked together by a molecular spacer to create a Bi-Specific Drug, used in combination with recombinant vaccines
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.